相关实验视频
Updated: Mar 14, 2026

05:44
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
1.4K
在炎症性皮肤病中与生物疗法相关的心血管结果:系统性审查
Mohamed Eghleilib1, Muaad Eghlileb2, Ahmed Eghlileb3
1Internal Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, GBR.
Cureus
|March 13, 2026
概括
生物疗法,特别是TNF-α抑制剂,可以通过向全身炎症来降低炎症性皮肤疾病中的心血管风险. 然而,药物类别的益处各不相同,需要进一步的长期研究.
科学领域:
- 皮肤病学和心血管医学
- 免疫学和药理学
背景情况:
- 像牛皮这样的皮肤病中的慢性系统性炎症与动脉样硬化和心血管事件有关.
- 针对皮肤疾病的促炎性细胞因子也是心血管疾病的关键.
- 生物疗法可以通过减少血管炎症来提供心血管益处.
研究的目的:
- 系统地审查和定性地分析生物疗法在炎症性皮肤病中的心血管影响的证据.
- 探索将生物治疗与心血管结果联系起来的潜在机制.
- 评估针对TNF-α,IL-12/23,IL-17,IL-23和IL-4/13的生物药物的心血管安全性和疗效.
主要方法:
- 在PubMed,Embase和Cochrane图书馆 (2005-2025) 的系统文献搜索.
- 包括关于使用特定生物制剂治疗的牛皮,牛皮性关节炎,补充性海炎和亚托皮炎的研究.
- 随机对照试验 (RCT),队列研究,注册表研究和评估主要心血管不良事件 (MACE) 和代用标记的机制研究的分析.
主要成果:
- 瘤坏死因子α (TNF-α) 抑制剂显示出最强有力的证据,观察性研究表明MACE与传统疗法相比降低,但严重心力衰竭的潜在风险较大.
- 机械学研究始终表明替代心血管标志物 (CRP,内皮功能,动脉硬,血管炎症) 的改善.
- 其他生物药物 (IL-12/23,IL-17,IL-23,IL-4/13抑制剂) 显示出一般的心血管安全性,但没有一致的MACE降低;对RISANKIZUMAB (IL-23抑制剂) 发现了脑血管事件的安全信号.
结论:
- 生物疗法,特别是TNF-α抑制剂,在炎症性皮肤疾病中显示出潜在的心血管益处.
- 证据在生物类之间不一致,受研究设计和对较新的药物有限的长期数据的影响.
- 系统性炎症控制是心血管改善的可能机制,但其在生物类中的统一性仍然不确定.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
693
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
693
Inflammatory Bowel Disease IV: Pharmacological Management
893
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
893
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
636
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
636
Drug Products: Biologics, Biosimilars and Interchangeables
336
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
336
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
593
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
593
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K

